Galera Therapeuticsincis A Biopharmaceutical Company Focused On Developing Innovative Treatments For Cancer Patientsthe Company Aims To Transform Radiotherapy By Reducing Its Toxicities And Enhancing Its Effectivenessgalera S Mission Is To Improve Patient Care And Quality Of Life Through Novel Therapeutic Approaches The Company Is Pioneering The Use Of Superoxide Dismutase Mimeticswhich Are Designed To Mitigate The Side Effects Of Radiotherapy While Increasing Its Anti Cancer Effectivenessgalera S Pipeline Includes Therapeutic Candidates That Target Patients Undergoing Radiation Therapyparticularly Those With Breast Cancer And Other Types Of Cancerunder The Leadership Of President And Ceo Mel Sorensenmdgalera Is Dedicated To Advancing Cancer Treatments Through Innovative Science
